Evidence map›Paper›PMID 36364306›Full record

ArticleMolecules (Basel, Switzerland)2022

Medicinal Values and Potential Risks Evaluation of

Xiaojia Su, Ruirui Shi, Haiyan Hu, Linfeng Hu, Qichao Wei, Yuanyuan Guan, Jingling Chang, Chengwei Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xiaojia SuCollege of Life Science and Technology, Henan Institute of Science and Technology, Xinxiang 453000, China.
Ruirui ShiCollege of Life Science and Technology, Henan Institute of Science and Technology, Xinxiang 453000, China.
Haiyan HuCollege of Life Science and Technology, Henan Institute of Science and Technology, Xinxiang 453000, China.
Linfeng HuCollege of Chemistry and Chemical Engineering, Henan Institute of Science and Technology, Xinxiang 453000, China.
Qichao WeiCollege of Life Science and Technology, Henan Institute of Science and Technology, Xinxiang 453000, China.
Yuanyuan GuanCollege of Life Science and Technology, Henan Institute of Science and Technology, Xinxiang 453000, China.
Jingling ChangCollege of Life Science and Technology, Henan Institute of Science and Technology, Xinxiang 453000, China.
Chengwei LiCollege of Biological Engineering, Henan University of Technology, Zhengzhou 450001, China.ORCID 0000-0002-3614-2276
Henan Institute of Science and Technology · CNHenan University of Technology · CN

Funding

National Nature Science Foundation of China 32101568Scientific and Technological Research Project of Henan Province,China 202102310194 and 212102110148
6 · The paper itself

Abstract

Ginkgo tea and ginkgo wine are two familiar

Indexed as

AntioxidantsGinkgo bilobaDietary SupplementsFlavonoidsPlant ExtractsPlant LeavesSalicylatesTeaTerpenesAntioxidantsFlavonoidsginkgolic acidPlant ExtractsSalicylatesTeaTerpenesacceptable daily intakedietary supplementsGBE drinksginkgolic acidspharmacodynamic ingredientsquality

Identifiers

PMID36364306
PMCPMC9658157
OpenAlexW4309090456

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.